Harrow Health, Inc. (HROW)

Harrow Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	138.68	130.19	88.6	72.48	48.87	51.17
Revenue Growth (YoY)	49.79%	46.95%	22.24%	48.30%	-4.48%	23.67%
Cost of Revenue	41.92	39.64	25.38	18.21	14.46	16.75
Gross Profit	96.76	90.55	63.21	54.26	34.41	34.42
Selling, General & Admin	96.02	83.09	58.24	41.32	31.25	33.09
Research & Development	8.07	6.65	3.05	11.08	2.41	2.08
Other Operating Expenses	0.38	0.38	0	0.25	0.36	4.04
Operating Expenses	104.46	90.12	61.29	52.65	34.02	39.21
Operating Income	-7.71	0.43	1.92	1.61	0.39	-4.8
Interest Expense / Income	21.99	21.32	7.24	5.44	2.24	2.5
Other Expense / Income	0.65	2.82	8.69	14.05	1.5	-7.47
Pretax Income	-30.34	-23.71	-14.01	-17.87	-3.35	0.18
Income Tax	0.99	0.7	0.08	0.13	0	0.01
Net Income	-31.33	-24.41	-14.09	-18.01	-3.36	0.17
Preferred Dividends	0	0	0	0.47	0	0
Net Income Common	-31.33	-24.41	-14.09	-18.48	-3.36	0.17
Net Income Growth	-	-	-	-	-	-98.85%
Shares Outstanding (Basic)	35	33	27	27	26	25
Shares Outstanding (Diluted)	35	33	27	27	26	26
Shares Change	17.10%	18.78%	2.63%	3.33%	-2.16%	11.15%
EPS (Basic)	-0.92	-0.75	-0.51	-0.69	-0.13	0.01
EPS (Diluted)	-0.92	-0.75	-0.51	-0.69	-0.13	0.01
EPS Growth	-	-	-	-	-	-98.36%
Free Cash Flow	6.37	2.38	-0.86	3.3	-1.96	-0.52
Free Cash Flow Per Share	0.18	0.07	-0.03	0.12	-0.08	-0.02
Gross Margin	69.77%	69.55%	71.35%	74.87%	70.41%	67.26%
Operating Margin	-5.56%	0.33%	2.17%	2.23%	0.79%	-9.37%
Profit Margin	-22.59%	-18.75%	-15.90%	-25.50%	-6.87%	0.33%
Free Cash Flow Margin	4.59%	1.83%	-0.97%	4.55%	-4.01%	-1.01%
Effective Tax Rate	-	-	-	-	-	4.55%
EBITDA	4.49	9.95	-3.1	-10.04	1.63	5.34
EBITDA Margin	3.24%	7.65%	-3.50%	-13.86%	3.33%	10.43%
Depreciation & Amortization	12.84	12.34	3.67	2.4	2.74	2.66
EBIT	-8.35	-2.39	-6.77	-12.44	-1.12	2.68
EBIT Margin	-6.02%	-1.83%	-7.64%	-17.16%	-2.29%	5.23%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).